文献速递慢性肾脏病水电解质与酸碱

CKD患者矿物质代谢标志物的纵向演变:CRIC研究

Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
PubMed 文献 · Am J Kidney Dis · 2019-10-23

该研究基于CRIC队列,对847例后续进展至ESKD的CKD患者进行ESKD锚定的纵向分析,评估ESKD前8年内FGF-23、PTH、血磷和血钙的系列变化。结果显示FGF-23水平在ESKD前约5年开始显著升高并持续加速上升,其变化速率和加速度均高于其他矿物质代谢标志物。

要点

  • FGF-23在ESKD前约5年开始升高并持续加速,变化速率最大
  • PTH和血磷升幅较小,血钙仅轻微下降
  • ESKD前活性维生素D和磷结合剂使用增加,PTH和血磷变化略有减速

核心结论

  • 在进展性CKD患者中,FGF-23水平在ESKD前5年开始升高并持续加速直至进入ESKD。

研究设计与样本

  • 研究为嵌套于CRIC队列的回顾性分析,纳入847例有最多5次年度测量且后续进展至ESKD的CKD患者。

主要发现

  • 随着距ESKD时间缩短,FGF-23平均水平显著升高,PTH和血磷轻度升高,血钙轻微下降。
  • FGF-23的变化速率和加速度幅度均高于其他矿物质代谢标志物,约在ESKD前5年显现并持续至ESKD无减速。
  • PTH和血磷变化速率轻度增加且无明显加速,在ESKD前即刻轻度减速,同时活性维生素D和磷结合剂使用增加。

临床怎么用

  • 对进展性CKD患者,可关注FGF-23在ESKD前约5年的上升趋势,作为矿物质代谢紊乱的早期标志。

局限性

  • 未研究CRIC研究中早期CKD且未进展至ESKD的个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: The pathogenesis of disordered mineral metabolism in chronic kidney disease (CKD) is largely informed by cross-sectional studies of humans and longitudinal animal studies. We sought to characterize the longitudinal evolution of disordered mineral metabolism during the course of CKD. STUDY DESIGN: Retrospective analysis nested in a cohort study. SETTING & PARTICIPANTS: Participants in the Chronic Renal Insufficiency Cohort (CRIC) Study who had up to 5 serial annual measurements of estimated glomerular filtration rate, fibroblast growth factor 23 (FGF-23), parathyroid hormone (PTH), serum phosphate, and serum calcium and who subsequently reached end-stage kidney disease (ESKD) during follow-up (n = 847). EXPOSURE: Years before ESKD. OUTCOMES: Serial FGF-23, PTH, serum phosphate, and serum calcium levels. ANALYTICAL APPROACH: To assess longitudinal dynamics of disordered mineral metabolism in human CKD, we used "ESKD-anchored longitudinal analyses" to express time as years before ESKD, enabling assessments of mineral metabolites spanning 8 years of CKD progression before ESKD. RESULTS: Mean FGF-23 levels increased markedly as time before ESKD decreased, while PTH and phosphate levels increased modestly and calcium levels declined minimally. Compared with other mineral metabolites, FGF-23 levels demonstrated the highest rate of change (velocity: first derivative of the function of concentration over time) and magnitude of acceleration (second derivative). These changes became evident approximately 5 years before ESKD and persisted without deceleration through ESKD onset. Rates of changes in PTH and phosphate levels increased modestly and without marked acceleration around the same time, with modest deceleration immediately before ESKD, when use of active vitamin D and phosphate binders increased. LIMITATIONS: Individuals who entered the CRIC Study at early stages of CKD and who did not progress to ESKD were not studied. CONCLUSIONS: Among patients with progressive CKD, FGF-23 levels begin to increase 5 years before ESKD and continue to rapidly accelerate until transition to ESKD.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Isakova T, Cai X, Lee J, et al. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2019. PMID: 31668375. doi:10.1053/j.ajkd.2019.07.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。